Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors.
- Published In:
- Pharmaceuticals (Basel, Switzerland), 18(11) (2025)
- Authors:
- Leupe, Hannes, Cauwenbergh, Merel, Cleeren, Frederik, Dekervel, Jeroen, Verslype, Chris, Deroose, Christophe M
- Database ID:
- RPEP-12048
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12048APA
Leupe, Hannes; Cauwenbergh, Merel; Cleeren, Frederik; Dekervel, Jeroen; Verslype, Chris; Deroose, Christophe M. (2025). Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors.. Pharmaceuticals (Basel, Switzerland), 18(11). https://doi.org/10.3390/ph18111608
MLA
Leupe, Hannes, et al. "Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors.." Pharmaceuticals (Basel, 2025. https://doi.org/10.3390/ph18111608
RethinkPeptides
RethinkPeptides Research Database. "Clinical Experience with Targeted Alpha-Emitter Peptide Rece..." RPEP-12048. Retrieved from https://rethinkpeptides.com/research/leupe-2025-clinical-experience-with-targeted
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.